Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Ignace Vergote Sandro Pignata Bradley J. Monk Jalid Sehouli John Farley Regina Berger Elsa Kalbacher Mansoor Raza Mirza Esther Drill Anneke Westermann Ignacio Romero Felix Hilpert Peter Vuylsteke Josep M. del Campo David M. O'Malley Cristina Churruca Gopa Iyer Kathleen N. Moore Nicoletta Colombo Robert L Coleman Susana Banerjee Rachel N. Grisham Martin K Oehler Carol Aghajanian Amit M. Oza Gunnar B. Kristensen Andrew R Clamp Christian Marth Isabelle Ray-Coquard David Cibula |
| Publication date | September 16, 2024 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |